Embolotherapy Market Forecast to 2028

Report Code : TIPRE00006432 | Region : Global | Industry : Medical Device | Published Date : 11/Aug/2022
Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological & Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the embolotherapy market growth. The market growth is attributed to a rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism. However, the availability of other alternative therapies and the high cost of embolization agents limit the market growth.

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils, or gel foam using an angiographic catheter. The catheter aids in blocking a blood vessel by implanting a balloon or any foreign body to treat bleeding ulcers, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defects, or control inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. According to National Cancer Registry (NCR), in 2020, ~110,000 new cancer cases were diagnosed in South Africa, with over 56,000 cancer-related deaths, representing a quarter of premature noncommunicable disease-related mortality. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cancer cases expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Further, in Denmark, the highest cancer rate for men and women combined was 334.9 people per 100,000. The age-standardized rate was at least 300 per 100,000 for ten countries: Denmark, Hungary, Ireland, Belgium, France, Australia, The Netherlands, Norway, France (New Caledonia), and Slovenia. In 2018, an estimated 233,000 women and 265,000 men in Germany were newly diagnosed with cancer. The total number of new cases per year has stagnated at around 500,000 for about ten years. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Based on the product, the embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents are further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices are further sub-segmented into microcatheters and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. The major driving factors for the growth of the embolic agents segment are the increasing use of embolic agents in various interventional radiology procedures and advancements in embolic agents.

Based on disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease, neurological disease, urological and nephrological disorder, gastrointestinal disorder, and others. The cancer is sub-segmented into liver cancer, kidney cancer, and other. The cancer segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the cancer segment are the rising incidences of cancer worldwide.

Based on disease indication, the embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the transcatheter arterial embolization (TAE) segment are the rising preference for minimally invasive procedures by the elderly, the growing prevalence of chronic diseases, and the rapid growth in the geriatric population.

Based on end user, the embolotherapy market is segmented into hospital & clinic, ambulatory surgical center, and other end user. In 2021, the hospital & clinic segment will likely hold the market's largest share. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028. The major driving factors for the growth of the hospitals & clinics segment are the growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), higher patient footfall in hospitals for the treatment of various diseases such as cancer, an increasing number of embolization procedures performed in these facilities, growing adoption of advance and cutting-edge embolotherapy devices to perform complex procedures with precision in a big hospital, small clinics, and critical care units.

COVID-19 Impact – Embolotherapy Market

In this scenario, the world observed enormous difficulties in managing cancers such as head and neck surgeries, chronic neurological disorders like brain aneurysms, and from headaches to neurodegenerative diseases. Due to inadequate monitoring, many patients are admitted to emergency departments due to decompensation of their cancer and neurological disease. During the COVID-19 pandemic, cancer, stroke patients, and other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties obtaining beds in the intensive care unit to manage the diseases during the acute phase.

The initial result was the cancellation of all elective hospital surgeries and procedures. While uterine fibroids are typically not threatened, some patients’ quality of life has been significantly impacted. Thus, the constraints imposed on accessing elective treatments, either to reduce cross-transmission of the virus or to schedule the hospital structure to assist infected patients, have caused women to live with discomfort and temporary treatments with slight effectiveness. For this reason, hospitals and public organizations have continued to offer Uterine Fibroid Embolization (UFE) during the COVID-19 pandemic. These factors were likely to have a negative impact in the initial phase on the market growth.

Various organic and inorganic strategies are adopted by companies in the embolotherapy market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the embolotherapy market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the embolotherapy market are listed below.

• In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil intended to impede or reduce blood flow in the peripheral vasculature. The newest addition to the Boston Scientific interventional oncology portfolio, the EMBOLD Fibered Coil, was designed for use in various embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow.

• In September 2021, Abbott announced that it acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.

A few major primary and secondary sources referred to while preparing the report on the embolotherapy market are the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Association of the British Pharmaceutical Industry (ABPI).

The List of Companies - Embolotherapy Market

1. Abbott Laboratories

2. Boston Scientific Corporation

3. Cook Medical LLC

4. Johnson & Johnson Consumer Inc

5. Medtronic

6. Acandis GmbH

7. Terumo Corporation

8. Balt USA LLC

9. Stryker Corporation

10. Guerbet LLC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Embolotherapy Market – by Product

1.3.2 Global Embolotherapy Market – by Disease Indication

1.3.3 Global Embolotherapy Market – by Procedure

1.3.4 Global Embolotherapy Market – by End User

1.3.5 Global Embolotherapy Market– By Geography

2. Embolotherapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Embolotherapy Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East & Africa– PEST Analysis

4.2.5 South & Central America – PEST Analysis

4.3 Expert Opinion

5. Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Cancer Cases

5.1.2 Rising Patient Preference for Minimally Invasive Procedures

5.1.3 Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Availability of Other Alternative Therapies

5.2.2 High Cost of Embolotherapy

5.3 Market Opportunity

5.3.1 Growing Applications of Embolotherapy

5.4 Market Trend

5.4.1 Increasing Use of Liquid Embolic Agents

5.5 Impact analysis

6. Embolotherapy Market– Global Analysis

6.1 Global Embolotherapy Market Revenue Forecast and Analysis

6.2 Global Embolotherapy Market, By Geography - Forecast and Analysis

6.2.1 Global Embolotherapy Market – Market Potential Analysis, By Region

6.3 Market Positioning of Key Players

6.3.1 Company Analysis

6.3.2 Growth Strategy Analysis

6.3.3 Performance Of Key Players

6.3.3.1 Cook Medical LLC

6.3.3.2 Boston Scientific Corporation

7. Embolotherapy Market Revenue and Forecasts To 2028 by Product

7.1 Overview

7.2 Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3 Embolic Agents

7.3.1 Overview

7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Microspheres

7.3.3.1 Overview

7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Embolic Coils

7.3.4.1 Overview

7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Embolic Plug Systems

7.3.5.1 Overview

7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Detachable Balloons

7.3.6.1 Overview

7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Liquid Embolic Agents

7.3.7.1 Overview

7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Support Devices

7.4.1 Overview

7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Microcatheters

7.4.3.1 Overview

7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Guidewires

7.4.4.1 Overview

7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8. Embolotherapy Market Analysis – By Disease Indication

8.1 Overview

8.2 Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3 Cancer

8.3.1 Overview

8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Liver Cancer

8.3.2.1.1 Overview

8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Kidney Cancer

8.3.2.2.1 Overview

8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Other Cancers

8.3.2.3.1 Overview

8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Peripheral Vascular Diseases

8.4.1 Overview

8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurological Diseases

8.5.1 Overview

8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Urological and Nephrological Disorders

8.6.1 Overview

8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Gastrointestinal Disorders

8.7.1 Overview

8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Embolotherapy Market Analysis – By Procedure

9.1 Overview

9.2 Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3 Transcatheter Arterial Embolization (TAE)

9.3.1 Overview

9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1 Overview

9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Transarterial Chemoembolization (TACE)

9.5.1 Overview

9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Embolotherapy Market Analysis – By End User

10.1 Overview

10.2 Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Other End Users

10.5.1 Overview

10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11. Embolotherapy Market – Geographic Analysis

11.1 North America: Embolotherapy Market

11.1.1 Overview

11.1.2 North America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3 North America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1 North America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2 North America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.4 North America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.4.1 North America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.5 North America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.6 North America Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.7 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.7.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2 US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2.1 US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2.2 US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3 US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3.1 US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.4 US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.5 US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.7.2 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2 Canada Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2.1 Canada Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2.2 Canada Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3 Canada Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3.1 Canada Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.4 Canada Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.5 Canada Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.7.3 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2 Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2.1 Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2.2 Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3 Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3.1 Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.4 Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.5 Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2 Europe: Embolotherapy Market

11.2.1 Overview

11.2.2 Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11.2.3 Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.3.1 Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.3.2 Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.4 Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.4.1 Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.5 Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.6 Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7 Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.2.7.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.2 Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.2.1 Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.2.2 Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.3 Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.3.1 Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.4 Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.5 Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7.2 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.1 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.2 France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.2.1 France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.2.2 France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.3 France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.3.1 France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.4 France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.5 France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7.3 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.1 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.2 UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.2.1 UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.2.2 UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.3 UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.3.1 UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.4 UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.5 UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7.4 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.1 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.2 Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.2.1 Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.2.2 Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.3 Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.3.1 Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.4 Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.5 Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7.5 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.1 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.2 Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.2.1 Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.2.2 Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.3 Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.3.1 Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.4 Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.5 Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.2.7.6 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.1 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.2 Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.2.1 Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.2.2 Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.3 Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.3.1 Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.4 Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.5 Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.3 Asia Pacific: Embolotherapy Market

11.3.1 Overview

11.3.2 Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11.3.3 Asia Pacific: Embolotherapy Market, by Product, – Revenue and Forecast to 2028 (US$ Million)

11.3.3.1 Asia Pacific Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.3.2 Asia Pacific Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

11.3.4 Asia Pacific Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.4.1 Asia Pacific Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.3.4.2 Asia Pacific Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.5 Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.3.6.1 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.1 Overview

11.3.6.1.2 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.3 China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.3.1 China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.3.2 China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.4 China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.4.1 China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.5 China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.1.6 China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6.2 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.1 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.2 Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.2.1 Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.2.2 Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.3 Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.3.1 Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.4 Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.2.5 Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.3.1 Overview

11.3.6.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.3.3 India: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.3.1 India: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.3.2 India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.4 India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.4.1 India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.5 India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.3.6 India: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.4.1 Overview

11.3.6.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.4.3 South Korea: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.3.2 South Korea: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.4 South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.4.1 South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.5 South Korea: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.4.6 South Korea: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.5.1 Overview

11.3.6.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.3.6.5.3 Australia: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.3.1 Australia: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.3.2 Australia: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.4 Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.4.1 Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.5 Australia: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.5.6 Australia: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.3.6.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.1 Overview

11.3.6.6.2 Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.3.6.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.4 Middle East & Africa: Embolotherapy Market

11.4.1 Overview

11.4.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.3 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.4.3.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.4.3.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.4.4 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.4.4.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.4.5 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.4.6 Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.4.7 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)

11.4.7.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.1.1 Overview

11.4.7.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.4.7.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.4.7.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.4.7.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.4.7.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.4.7.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.4.7.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.4.7.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.2.1 Overview

11.4.7.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.4.7.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.4.7.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.4.7.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.4.7.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.4.7.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.4.7.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.4.7.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.3.1 Overview

11.4.7.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.4.7.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.4.7.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.4.7.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.4.7.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.4.7.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.4.7.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.4.7.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.4.1 Overview

11.4.7.4.2 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.4.7.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.4.7.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.4.7.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.4.7.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.4.7.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.4.7.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.5 South and Central America: Embolotherapy Market

11.5.1 Overview

11.5.2 South and Central America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11.5.3 South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.5.3.1 South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.5.3.2 South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.5.4 South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.5.4.1 South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.5.5 South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.5.6 South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.5.7 South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.5.7.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.2 Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.2.1 Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.2.2 Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.3 Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.3.1 Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.4 Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.5.7.1.5 Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.5.7.2 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.1 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.2 Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.2.1 Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.2.2 Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.3 Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.3.1 Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.4 Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.5.7.2.5 Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.5.7.3 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.1 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.2 Rest of South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.2.1 Rest of South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.2.2 Rest of South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.3 Rest of South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.3.1 Rest of South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.4 Rest of South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.5.7.3.5 Rest of South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12. Impact of COVID-19 Pandemic on Global Embolotherapy Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Embolotherapy Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Boston Scientific Corporation

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Cook Medical LLC

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Johnson & Johnson

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Medtronic

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Acandis GmbH

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Balt USA LLC

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Stryker Corporation

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Guerbet LLC

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products

LIST OF TABLES.

Table 1. North America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 6. North America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7. North America Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8. US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12. US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 13. US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 14. US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)

Table 17. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)

Table 18. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)

Table 19. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)

Table 20. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)

Table 21. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)

Table 22. Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 24. Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 25. Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 27. Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 28. Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 29. Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 30. Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 31. Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 32. Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 33. Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 34. Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 35. Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 36. Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 37. Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 38. Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 39. Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 40. Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 41. Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 42. Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 43. France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 44. France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 45. France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 46. France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 47. France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 48. France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 49. France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 50. UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 51. UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 52. UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 53. UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 54. UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 55. UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 56. UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 57. Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 58. Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 59. Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 60. Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 61. Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 62. Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 63. Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 64. Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 65. Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 66. Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 67. Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 68. Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 69. Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 70. Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 71. Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 72. Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 73. Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 74. Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 75. Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 76. Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 77. Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 78. Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 79. Asia Pacific Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 80. Asia Pacific Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

Table 81. Asia Pacific Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 82. Asia Pacific Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 83. Asia Pacific Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 84. Asia Pacific Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 85. China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 86. China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 87. China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

Table 88. China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 89. China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 90. China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 91. China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 92. Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 93. Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 94. Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 95. Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 96. Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 97. Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 98. Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 99. India: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)

Table 100. India: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)

Table 101. India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 102. India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 103. India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 104. India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 105. India: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)

Table 106. South Korea: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)

Table 107. South Korea: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)

Table 108. South Korea: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)

Table 109. South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 110. South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 111. South Korea: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)

Table 112. South Korea: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)

Table 113. Australia: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)

Table 114. Australia: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)

Table 115. Australia: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)

Table 116. Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 117. Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 118. Australia: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)

Table 119. Australia: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)

Table 120. Rest of Asia Pacific: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)

Table 121. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)

Table 122. Rest of Asia Pacific: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)

Table 123. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 124. Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 125. Rest of Asia Pacific: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)

Table 126. Rest Of Asia Pacific: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)

Table 127. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million).

Table 128. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 129. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 130. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 131. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 132. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 133. Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 134. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 135. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 136. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 137. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 138. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 139. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 140. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 141. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 142. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 143. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 144. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 145. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 146. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 147. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 148. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 149. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 150. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 151. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 152. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 153. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 154. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 155. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 156. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 157. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 158. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 159. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 160. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 161. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 162. South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 163. South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 164. South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 165. South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 166. South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 167. South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 168. South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 169. Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 170. Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 171. Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 172. Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 173. Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 174. Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 175. Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 176. Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 177. Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 178. Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 179. Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 180. Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 181. Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 182. Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 183. Rest of South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 184. Rest of South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 185. Rest of South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 186. Rest of South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 187. Rest of South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 188. Rest of South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 189. Rest of South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 190. Organic Developments Done By Companies

Table 191. Inorganic Developments Done by Companies

Table 192. Glossary of Terms, Embolotherapy Market

The List of Companies - Embolotherapy Market

1. Abbott Laboratories

2. Boston Scientific Corporation

3. Cook Medical LLC

4. Johnson & Johnson Consumer Inc

5. Medtronic

6. Acandis GmbH

7. Terumo Corporation

8. Balt USA LLC

9. Stryker Corporation

10. Guerbet LLC.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global embolotherapy market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the global embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Embolotherapy Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry